1f
12
9
1a
8
20
8
49
16
8
19
1
49
2
8
1b
1d
18
89
3a
1d
2 29
1d
25
3a
Whitley Aamodt, MD, MPH, MSCE
77Assistant Professor of Neurology at the Hospital of the University of Pennsylvania
28
8a
3
60
Director, Parkinson's Disease and Movement Disorders Center, Palliative Care Clinic
11
Department: Neurology
4
1
b
1d
46
Contact information
5a
4
3
3
1d
5a
330 S. 9th Street
Philadelphia, PA 19107
26
Philadelphia, PA 19107
2e
Office: 215-829-6500
32 Fax: 215-829-6606
24
ab
12
32 Fax: 215-829-6606
24
18
Publications
23 a
3
2
29
23 a
Links
b9 Search PubMed for articles
d
4
b
1f
b9 Search PubMed for articles
d
13
Education:
21 7 BS 19 (Neuroscience) c
34 College of William and Mary, 2009.
21 8 MPH c
44 University of Texas School of Public Health, 2015.
21 7 MD c
4e University of Texas School of Medicine at San Antonio, 2015.
21 9 MSCE c
34 University of Pennsylvania , 2022.
c
3
3
21
21 7 BS 19 (Neuroscience) c
34 College of William and Mary, 2009.
21 8 MPH c
44 University of Texas School of Public Health, 2015.
21 7 MD c
4e University of Texas School of Medicine at San Antonio, 2015.
21 9 MSCE c
34 University of Pennsylvania , 2022.
c
1f
Post-Graduate Training
24 58 Intern, Department of Medicine, Baylor College of Medicine, 2015-2016.
24 5b Resident, Department of Neurology, University of Pennsylvania, 2016-2019.
24 b2 Edmond J. Safra Fellow in Movement Disorders, Department of Neurology, University of Pennsylvania and Corporal Michael J. Crescenz VA Medical Center, 2019-2021.
24 92 Research Fellow in Neuroepidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, 2020-2022.
c
3
25
24 58 Intern, Department of Medicine, Baylor College of Medicine, 2015-2016.
24 5b Resident, Department of Neurology, University of Pennsylvania, 2016-2019.
24 b2 Edmond J. Safra Fellow in Movement Disorders, Department of Neurology, University of Pennsylvania and Corporal Michael J. Crescenz VA Medical Center, 2019-2021.
24 92 Research Fellow in Neuroepidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, 2020-2022.
c
17
Certifications
28 43 American Board of Psychiatry and Neurology, 2019.
c
3
8d
Permanent link28 43 American Board of Psychiatry and Neurology, 2019.
c
2 29
21
1e
1d
24
2b
29
27
23
127 Aamodt WW, Bilker WB, Willis AW, Farrar JT.: Sociodemographic and Geographic Disparities in End-of-Life Health Care Intensity Among Medicare Beneficiaries With Parkinson Disease. Neurol Clin Pract 13(4): e200171, Aug 2023.
de Aamodt WW, Willis AW, Dahodwala N.: Racial and Ethnic Disparities in Parkinson Disease: A Call to Action. Neurol Clin Pract 13(2): e200138, Apr 2023.
12d Aamodt WW, Dubroff JG, Cheng G, Taylor B, Wood S, Duda JE, Morley JF.: Gait Abnormalities and Non-Motor Symptoms Predict Abnormal Dopaminergic Imaging in Presumed Drug-Induced Parkinsonism. NPJ Parkinsons Dis 8(1): 53, Apr 2022.
15b Aamodt WW, Waligorska T, Shen J, Tropea TF, Siderowf A, Weintraub D, Grossman M, Irwin D, Wolk DA, Xie SX, Trojanowski JQ, Shaw LM, Chen-Plotkin AS.: Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease. Mov Disord 36(12): 2945-2950, Dec 2021.
ee Aamodt WW, Travers J, Thibault D, Willis AW.: Hospital Magnet Status Associates With Inpatient Safety in Parkinson Disease. J Neurosci Nurs 53(3): 116-122, Jun 2021.
124 Terracina KA, Aamodt WW, Schillerstrom JE.: Executive Function Impairment and Recidivism in Adult Protective Services Clients Referred for a Decision Making Capacity Assessment. J Elder Abuse Negl 27(2): 91-9, Mar 2015.
f0 Aamodt WW, Terracina KA, Schillerstrom JE.: Cognitive Profiles of Elder Adult Protective Services Clients Living in Squalor. J Elder Abuse Negl 27(1): 65-73, Jan 2015.
114 Park DC, Lodi-Smith J, Drew L, Haber S, Hebrank A, Bischof GN, Aamodt W.: The Impact of Sustained Engagement on Cognitive Function in Older Adults: The Synapse Project. Psychol Sci 27(2): 91-9, Jan 2014.
2c
7
1d
1f
Selected Publications
d8 Aamodt W, Kluger B, Mirham M, Job A, Lettenberger S, Mosley P, Seshadri S. : Caregiver Burden in Parkinson Disease: A Scoping Review of the Literature from 2017-2022 4c J Geriatr Psychiatry Neuro 37(2): 96-113, Mar 2023.127 Aamodt WW, Bilker WB, Willis AW, Farrar JT.: Sociodemographic and Geographic Disparities in End-of-Life Health Care Intensity Among Medicare Beneficiaries With Parkinson Disease. Neurol Clin Pract 13(4): e200171, Aug 2023.
de Aamodt WW, Willis AW, Dahodwala N.: Racial and Ethnic Disparities in Parkinson Disease: A Call to Action. Neurol Clin Pract 13(2): e200138, Apr 2023.
12d Aamodt WW, Dubroff JG, Cheng G, Taylor B, Wood S, Duda JE, Morley JF.: Gait Abnormalities and Non-Motor Symptoms Predict Abnormal Dopaminergic Imaging in Presumed Drug-Induced Parkinsonism. NPJ Parkinsons Dis 8(1): 53, Apr 2022.
15b Aamodt WW, Waligorska T, Shen J, Tropea TF, Siderowf A, Weintraub D, Grossman M, Irwin D, Wolk DA, Xie SX, Trojanowski JQ, Shaw LM, Chen-Plotkin AS.: Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease. Mov Disord 36(12): 2945-2950, Dec 2021.
ee Aamodt WW, Travers J, Thibault D, Willis AW.: Hospital Magnet Status Associates With Inpatient Safety in Parkinson Disease. J Neurosci Nurs 53(3): 116-122, Jun 2021.
124 Terracina KA, Aamodt WW, Schillerstrom JE.: Executive Function Impairment and Recidivism in Adult Protective Services Clients Referred for a Decision Making Capacity Assessment. J Elder Abuse Negl 27(2): 91-9, Mar 2015.
f0 Aamodt WW, Terracina KA, Schillerstrom JE.: Cognitive Profiles of Elder Adult Protective Services Clients Living in Squalor. J Elder Abuse Negl 27(1): 65-73, Jan 2015.
114 Park DC, Lodi-Smith J, Drew L, Haber S, Hebrank A, Bischof GN, Aamodt W.: The Impact of Sustained Engagement on Cognitive Function in Older Adults: The Synapse Project. Psychol Sci 27(2): 91-9, Jan 2014.
2c